During the past decade, Hopital Uni Ire Dupuytren; Hematologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Uni Ire Dupuytren; Hematologie" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator and "The Lymphoma Academic Research Organisation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Uni Ire Dupuytren; Hematologie" are "B-cell Lymphoma" (1 trials), "Burkitt Lymphoma (BL))" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Diffuse Large B Lymphoma (DLBCL)" (1 trials) and "Diffuse Large B-Cell Lymphoma" (1 trials). Many other conditions were trialed in "Hopital Uni Ire Dupuytren; Hematologie" in a lesser frequency.

Most popular intervention types in "Hopital Uni Ire Dupuytren; Hematologie" are "Drug" (4 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (3 trials), "Cyclophosphamide" (2 trials), "Bendamustine" (1 trials), "Bevacizumab" (1 trials) and "CHOP" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Uni Ire Dupuytren; Hematologie" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Uni Ire Dupuytren; Hematologie". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hopital Uni Ire Dupuytren; Hematologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Uni Ire Dupuytren; Hematologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".